CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- 4 Grant or award EVP, Chief Medical Officer acquired 9,028 shares (grant or award)
- 4 Grant or award EVP and CIO acquired 9,652 shares (grant or award)
- 4 Grant or award EVP & President CHCI acquired 19,445 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy EVP & CHRO bought 6,371 shares at an average $25.90 ($164,977)
- 4 Open-market buy CEO bought 9,500 shares at $26.54 ($252,168)
- 4 Open-market buy EVP & CHRO bought 5,550 shares at $31.01 ($172,106)
- 4 Open-market buy EVP & Chief Scientific Officer bought 2,040 shares at $29.34 ($59,854)
- 4 Open-market buy EVP & Chief Financial Officer bought 5,000 shares at $29.18 ($145,882)
- 4 Open-market buy CEO bought 11,000 shares at $28.99 ($318,868)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP & Chief Scientific Officer acquired 738 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 5,478 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP & Chief Scientific Officer acquired 920 shares (option exercise)
- 4 Option exercise EVP & General Counsel acquired 12,409 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $33.06 ($330,637)
Page 9 of 41 · 805 filings